 low-molecular-weight heparin; OR, odds ratio; PAD, peripheral arterial disease; RCT, randomized
controlled trial.

JOURNAL OF VASCULAR SURGERY
Volume 61, Number 3S

within the graft or at the anastomoses thought to threaten
graft patency, regardless of clinical presentation.
There is an extensive body of literature on the use DUS
of lower extremity vein grafts performed for CLI. Most
studies